Abstract
Annulated 1,8-naphthyridines were synthesized by one-pot reaction of aromatic aldehyde, malononitrile dimer and enehydrazinoketone.
Introduction
The naphthyridine moiety is part of many biologically active compounds possessing antimalarial [1], antibacterial [2], [3], anti-inflammatory [4], [5], [6], antiproliferative [7], [8], anticancer [9], [10], [11] and antioxidant activity [12]. In addition, naphthyridine derivatives are used as catalysts [13], [14], [15], fluorescent dyes [16] and sensors [17], [18]. Generally, 1,8-naphthyridines are synthesized by the Friedländer reaction and its modifications using pyridine derivatives as starting materials [19], [20], [21]. In recent years, multicomponent reactions have gained significant attention and have been used for the synthesis of polyfunctional compounds [22], [23], [24], [25], [26], [27]. In the current work, naphthyridines were synthesized from an aromatic aldehyde, the malononitrile dimer and a 3-hydrazinylcyclohex-2-en-1-one through a sequential Michael reaction followed by two sequential heterocyclizations involving amine additions to nitriles.
Results and discussion
Previously, we have described a new method for obtaining 5H-chromeno[2,3-b]pyridines and 1,4-dihydro-1,8-naphthyridines by using double heteroannulation reactions of Michael adducts (DHARMA) strategy [28], [29], [30], [31]. As part of our continued research, we have extended our method to obtain 2,4,10-triamino-6-oxo-5-aryl-5,6,7,8,9,10-hexahydrobenzo[b][1,8]naphthyridine-3-carbonitrile derivatives 2a–j by the reaction of arylmethylidene derivatives of malononitrile dimer 1 and enehydrazinoketones (Scheme 1).
![Scheme 1 Synthesis of 2,4,10-triamino-6-oxo-5-aryl-5,6,7,8,9,10-hexahydrobenzo[b][1,8]naphthyridine-3-carbonitrile derivatives 2a–j.](/document/doi/10.1515/hc-2017-0068/asset/graphic/j_hc-2017-0068_scheme_001.jpg)
Synthesis of 2,4,10-triamino-6-oxo-5-aryl-5,6,7,8,9,10-hexahydrobenzo[b][1,8]naphthyridine-3-carbonitrile derivatives 2a–j.
The presence of the nucleophilic and electrophilic centers in the Michael adduct A permits intramolecular heterocyclizations, leading to the formation of 1,8-naphthyridine 2. Thus, following the Michael addition, the first pyridine is formed by nucleophilic attack of the enehydrazine nitrogen atom to the proximal cyano group. The resulting amine B is then captured by the cyano group of the dicyanomethylene moiety to give compound 2.
The most effective way of constructing condensed heterocycles from simple substrates is the use of a multicomponent reaction. This strategy lowers the number of steps, as well as the amount of chemicals, thereby reducing the energy consumption of the process and increasing yield of the product. In this work, a three-component system comprising of aromatic aldehyde, malononitrile dimer and enehydrazinoketone was used to carry out a tandem Knoevenagel–Michael reaction that led to 1,4-dihydro-1,8-naphthyridines 2 in 65%–90% yields.
The structures of compounds 2a–j were confirmed by spectral methods. 1H NMR spectra taken at 27°C indicate that compounds 2g–j exist as diastereomers because of the slow rate of inversion of the nitrogen atom of the dihydropyridine ring (Figure 1). To confirm this analysis, the 1H NMR spectrum of 2g was acquired at 70°C. As expected, a simpler spectrum due to averaging of signals is observed at the higher temperature.

1H NMR spectra of compound 2g at 27°C and at 70°C.
Conclusion
A one-pot synthesis scheme of new 1,8-naphthyridines involves a double heteroannulation reaction.
Experimental
Progress of all reactions and purity of compounds were analyzed by TLC on Silufol UV-254 plates (development by UV irradiation, exposure to iodine vapor or thermal decomposition). IR spectra were recorded on an FT-IR spectrophotometer FSM-1202 using mulls in mineral oil. 1H NMR spectra were registered on a spectrometer Bruker DRX-500 (500.13 MHz) in DMSO-d6 using TMS as the internal standard. Mass spectra (EI, 70 eV) were obtained using a Finnigan MAT INCOS-50 instrument. The signals of a second isomer in NMR spectra of compounds 2g–j are indicated by an asterisk.
General procedure for the synthesis of a series of 2,4-diamino-6-oxo-5-aryl-5,6,7,8,9,10-hexahydrobenzo[b][1,8]naphthyridine-3-carbonitriles 2
A solution of enehydrazinoketone (10 mmol) and piperidine in EtOH (10 mL) was added to a mixture of aromatic aldehyde (10 mmol) and malononitrile dimer (10 mmol) in EtOH (10 mL). The mixture was stirred at 40–50°C for 30 min and the resulting precipitate was filtered and washed with i-PrOH. Crude products were crystallized from a mixture of dioxane and acetonitrile.
2,4-Diamino-10-(dimethylamino)-8,8-dimethyl-6-oxo-5-phenyl-5,6,7,8,9,10-hexahydrobenzo[b][1,8]naphthyridine-3-carbonitrile (2a)
This compound was obtained in 70% yield (0.28 g) as a pale yellow solid; mp 237–238°C (dec); 1H NMR: δ 0.78 (s, 3H, CH3), 1.02 (s, 3H, CH3), 1.96 (d, 1H, J=16 Hz, CH2), 2.17 (d, 1H, J=16 Hz, CH2), 2.48 (d, 1H, J=17 Hz, CH2), 2.92 (d, 1H, J=17 Hz, CH2), 2.98 (s, 3H, N(CH3)2), 3.00 (s, 3H, N(CH3)2), 5.03 (s, 1H, CH), 6.08 (s, 2H, NH2), 6.25 (s, 2H, NH2), 7.06 (t, 1H, J=7 Hz, C6H5), 7.16 (t, 2H, J=7 Hz, C6H5), 7.23 (d, 2H, J=7 Hz, C6H5); IR: 3456, 3427, 3337 (NH2), 2190 (CN), 1630 cm−1 (C=O); MS: m/z (%) 402 [M]+ (10), 358 [M–44]+ (25), 325 [M–77]+ (38), 281 [M–120]+ (100). Anal. Calcd for C23H26N6O: C, 68.63; H, 6.51; N, 20.88. Found: C, 68.77; H, 6.42; N, 20.72.
2,4-Diamino-10-(dimethylamino)-5-(4-fluorophenyl)-8,8-dimethyl-6-oxo-5,6,7,8,9,10-hexahydrobenzo[b][1,8]naphthyridine-3-carbonitrile (2b)
This compound was obtained in 76% yield (0.32 g) as a white solid; mp 254–255°C (dec); 1H NMR: δ 0.78 (s, 3H, CH3), 1.02 (s, 3H, CH3), 1.96 (d, 1H, J=16 Hz, CH2), 2.17 (d, 1H, J=16 Hz, CH2), 2.48 (d, 1H, J=17 Hz, CH2), 2.92 (d, 1H, J=17 Hz, CH2), 2.98 (s, 3H, N(CH3)2), 3.00 (s, 3H, N(CH3)2), 5.06 (s, 1H, CH), 6.14 (s, 2H, NH2), 6.27 (s, 2H, NH2), 6.99 (t, 2H, J=9 Hz, C6H4), 7.25 (dd, 2H, J=9 Hz, J=6 Hz, C6H4); IR: 3459, 3320 (NH2), 2190 (CN), 1680 cm−1 (C=O); MS: m/z (%) 420 [M]+ (18), 377 [M–43]+ (100), 325 [M–95]+ (59). Anal. Calcd for C23H25FN6O: C, 65.70; H, 5.99; N, 19.99. Found: C, 65.54; H, 5.87; N, 20.12.
2,4-Diamino-10-(dimethylamino)-8,8-dimethyl-6-oxo-5-(p-tolyl)-5,6,7,8,9,10-hexahydrobenzo[b][1,8]naphthyridine-3-carbonitrile (2c)
This compound was obtained in 67% yield (0.28 g) as a pale yellow solid; mp 265–266°C (dec); 1H NMR: δ 0.79 (s, 3H, CH3), 1.02 (s, 3H, CH3), 1.95 (d, 1H, J=16 Hz, CH2), 2.16 (d, 1H, J=16 Hz, CH2), 2.18 (s, 3H, CH3), 2.47 (d, 1H, J=18 Hz, CH2), 2.91 (d, 1H, J=18 Hz, CH2), 2.97 (s, 3H, N(CH3)2), 3.00 (s, 3H, N(CH3)2), 4.97 (s, 1H, CH), 6.03 (s, 2H, NH2), 6.23 (s, 2H, NH2), 6.96 (d, 2H, J=8 Hz, C6H4), 7.11 (d, 2H, J=8 Hz, C6H4); IR: 3430, 3333, 3239 (NH2), 2187 (CN), 1641 cm−1 (C=O); MS: m/z (%) 416 [M]+ (20), 373 [M–43]+ (90), 325 [M–91]+ (50), 282 [M–134]+ (100). Anal. Calcd for C24H28N6O: C, 69.21; H, 6.78; N, 20.18. Found: C, 69.08; H, 6.79; N, 20.30.
2,4-Diamino-5-(3-chlorophenyl)-10-(dimethylamino)-8,8-dimethyl-6-oxo-5,6,7,8,9,10-hexahydrobenzo[b][1,8]naphthyridine-3-carbonitrile (2d)
This compound was obtained in 80% yield (0.35 g) as a pale yellow solid; mp 251–252°C (dec); 1H NMR: δ 0.78 (s, 3H, CH3), 1.02 (s, 3H, CH3), 1.98 (d, 1H, J=16 Hz, CH2), 2.18 (d, 1H, J=16 Hz, CH2), 2.48 (d, 1H, J=18 Hz, CH2), 2.92 (d, 1H, J=18 Hz, CH2), 2.98 (s, 3H, N(CH3)2), 3.00 (s, 3H, N(CH3)2), 5.07 (s, 1H, CH), 6.22 (s, 2H, NH2), 6.30 (s, 2H, NH2), 7.08–7.14 (m, 2H, C6H4), 7.21 (t, 1H, J=8 Hz, C6H4), 7.37 (t, 1H, J=2 Hz, C6H4); IR: 3465, 3343, 3211 (NH2), 2196 (CN), 1625 cm−1 (C=O); MS: m/z (%) 436 [M]+ (3), 393 [M–43]+ (20). Anal. Calcd for C23H25ClN6O: C, 63.22; H, 5.77; N, 19.23. Found: C, 63.09; H, 5.86; N, 19.37.
2,4-Diamino-10-(dimethylamino)-6-oxo-5-phenyl-5,6,7,8,9,10-hexahydrobenzo[b][1,8]naphthyridine-3-carbonitrile (2e)
This compound was obtained in 65% yield (0.24 g) as a pale yellow solid; mp 239–240°C (dec); 1H NMR: δ 1.60–1.69 (m, 2H, CH2), 1.88–1.94 (m, 2H, CH2), 2.12–2.24 (m, 2H, CH2), 2.98 (s, 3H, CH3), 3.01 (s, 3H, CH3), 5.07 (s, 1H, CH), 6.08 (s, 2H, NH2), 6.24 (s, 2H, NH2), 7.06 (t, 1H, J=7 Hz, C6H5), 7.14–7.25 (m, 4H, C6H5); IR: 3474, 3360 (NH2), 2201 (CN), 1650 cm−1 (C=O); MS: m/z (%) 374 [M]+ (5), 330 [M–44]+ (16), 297 [M–77]+ (25), 254 [M–120]+ (100). Anal. Calcd for C21H22N6O: C, 67.36; H, 5.92; N, 22.44. Found: C, 67.50; H, 5.83; N, 22.35.
2,4-Diamino-10-(dimethylamino)-5-(4-fluorophenyl)-6-oxo-5,6,7,8,9,10-hexahydrobenzo[b][1,8]naphthyridine-3-carbonitrile (2f)
This compound was obtained in 68% yield (0.27 g) as a pale yellow solid; mp 237–238°C (dec); 1H NMR: δ 1.64–1.68 (m, 2H, CH2), 1.89–1.94 (m, 2H, CH2), 2.14–2.22 (m, 2H, CH2), 2.97 (s, 3H, CH3), 3.01 (s, 3H, CH3), 5.09 (s, 1H, CH), 6.13 (s, 2H, NH2), 6.24 (s, 2H, NH2), 6.98 (t, 2H, J=9 Hz, C6H4), 7.23 (m, 4H, C6H4); IR: 3460, 3340 (NH2), 2204 (CN), 1656 cm−1 (C=O); MS: m/z (%) 392 [M]+ (1), 348 [M–44]+ (4), 254 [M–138]+ (43). Anal. Calcd for C21H21FN6O: C, 64.27; H, 5.39; N, 21.42. Found: C, 64.38; H, 5.28; N, 21.30.
2,4-Diamino-8,8-dimethyl-6-oxo-5-phenyl-10-(phenylamino)-5,6,7,8,9,10-hexahydrobenzo[b][1,8]naphthyridine-3-carbonitrile (2g)
This compound was obtained in 70% yield (0.32 g) as a white solid; mp 229–230°C (dec); 1H NMR: δ 0.76 (s, 3H, CH3)*, 0.79 (s, 3H, CH3), 0.93 (s, 3H, CH3)*, 0.99 (s, 3H, CH3), 1.97 (d, 1H, J=17 Hz, CH2)*, 2.11 (d, 1H, J=16 Hz, CH2), 2.21 (d, 1H, J=14 Hz, CH2)*, 2.24 (d, 1H, J=16 Hz, CH2), 2.28 (d, 1H, J=18.0 Hz, CH2)*, 2.48 (d, 1H, J=18 Hz, CH2), 2.64 (d, 1H, J=18 Hz, CH2), 2.89 (d, 1H, J=17 Hz, CH2)*, 5.16 (s, 1H, CH)*, 5.31 (s, 1H, CH), 5.80 (s, 2H, NH2)*, 6.11 (s, 2H, NH2), 6.16 (s, 2H, NH2)*, 6.29 (s, 2H, NH2), 6.56 (d, 2H, J=8 Hz, C6H5)*, 6.71 (d, 2H, J=8 Hz, C6H5), 6.74 (t, 1H, J=7 Hz, C6H5)*, 6.81 (t, 1H, J=7 Hz, C6H5), 7.08 (t, 1H, J=7 Hz, C6H5)*, 7.12–7.27 (m, 7H, 2C6H5), 7.12–7.27 (m, 4H, 2C6H5)*, 7.35 (d, 2H, J=7 Hz, C6H5)*, 8.21 (s, 1H, NH), 8.62 (s, 1H, NH)*; IR: 3430, 3347 (NH2), 3217 (NH), 2196 (CN), 1620 cm−1 (C=O); MS: m/z (%) 450 [M]+ (55), 373 [M–77]+ (95), 358 [M–92]+ (56), 282 [M–168]+ (100). Anal. Calcd for C27H26N6O: C, 71.98; H, 5.82; N, 18.65. Found: C, 71.88; H, 5.90; N, 18.78.
2,4-Diamino-5-(2-chlorophenyl)-8,8-dimethyl-6-oxo-10-(phenylamino)-5,6,7,8,9,10-hexahydrobenzo[b][1,8]naphthyridine-3-carbonitrile (2h)
This compound was obtained in 90% yield (0.44 g) as a white solid; mp 225–226°C (dec); 1H NMR: δ 0.82 (s, 3H, CH3)*, 0.86 (s, 3H, CH3), 0.95 (s, 3H, CH3)*, 1.00 (s, 3H, CH3), 1.93 (d, 1H, J=16 Hz, CH2)*, 2.01 (d, 1H, J=17 Hz, CH2), 2.19 (d, 1H, J=16 Hz, CH2)*, 2.21 (d, 1H, J=16 Hz, CH2), 2.31 (d, 1H, J=18 Hz, CH2)*, 2.59 (d, 1H, J=17 Hz, CH2), 2.74 (d, 1H, J=18 Hz, CH2), 2.93 (d, 1H, J=17 Hz, CH2)*, 5.25 (s, 1H, CH), 5.29 (s, 1H, CH)*, 5.82 (s, 2H, NH2), 5.82 (s, 2H, NH2)*, 5.92 (s, 2H, NH2)*, 6.17 (s, 2H, NH2), 6.62 (d, 2H, J=8 Hz, C6H5)*, 6.76 (t, 1H, J=7 Hz, C6H5)*, 6.89 (t, 1H, J=7 Hz, C6H5), 6.95 (d, 2H, J=8 Hz, C6H5), 7.13–7.36 (m, 2H, C6H5)*, 7.13–7.36 (m, 2H, C6H5), 7.13–7.36 (m, 3H, C6H4), 7.13–7.36 (m, 3H, C6H4)*, 7.47 (dd, 1H, J=8 Hz, J=1.6 Hz, C6H4)*, 7.54 (d, 1H, J=7 Hz, C6H4), 8.19 (s, 1H, NH), 8.59 (s, 1H, NH)*; IR: 3383, 3312 (NH2), 3205 (NH), 2190 (CN), 1630 (C=O); MS: m/z (%) 484 [M]+ (5). Anal. Calcd for C27H25ClN6O: C, 66.87; H, 5.20; N, 17.33. Found: C, 66.74; H, 5.09; N, 17.47.
2,4-Diamino-8,8-dimethyl-6-oxo-10-(phenylamino)-5-(p-tolyl)-5,6,7,8,9,10-hexahydrobenzo[b][1,8]naphthyridine-3-carbonitrile (2i)
This compound was obtained in 70% yield (0.33 g) as a pale yellow solid; mp 234–235°C (dec); 1H NMR: δ 0.77 (s, 3H, CH3)*, 0.80 (s, 3H, CH3), 0.93 (s, 3H, CH3)*, 0.99 (s, 3H, CH3), 1.96 (d, 1H, J=16 Hz, CH2)*, 2.09 (d, 1H, J=16 Hz, CH2), 2.20 (s, 3H, CH3)*, 2.23 (s, 3H, CH3), 2.24 (d, 1H, J=16 Hz, CH2), 2.28 (d, 1H, J=18 Hz, CH2)*, 2.48 (d, 1H, J=18 Hz, CH2), 2.52 (d, 1H, J=18 Hz, CH2)*, 2.64 (d, 1H, J=18 Hz, CH2), 2.88 (d, 1H, J=18 Hz, CH2)*, 5.10 (s, 1H, CH)*, 5.24 (s, 1H, CH), 5.79 (s, 2H, NH2)*, 6.10 (s, 2H, NH2), 6.11 (s, 2H, NH2)*, 6.22 (s, 2H, NH2), 6.56 (d, 2H, J=8 Hz, C6H5)*, 6.74–6.76 (m, 2H, C6H5), 6.74–6.76 (m, 1H, C6H5)*, 6.82 (t, 1H, J=7 Hz, C6H5), 6.98 (d, 2H, J=8 Hz, C6H4), 7.02 (d, 2H, J=8 Hz, C6H4)*, 7.13–7.19 (m, 2H, C6H5), 7.13–7.19 (m, 2H, C6H5)*, 7.13–7.19 (m, 1H, C6H4), 7.23 (d, 1H, J=8 Hz, C6H4)*, 8.21 (s, 1H, NH), 8.61 (s, 1H, NH)*; IR: 3494, 3302 (NH2), 3234 (NH), 2200 (CN), 1660 cm−1 (C=O); MS: m/z (%) 464 [M]+ (10), 373 [M–91]+ (43), 282 [M–182]+ (67), 93 [M–371]+ (100). Anal. Calcd for C28H28N6O: C, 72.39; H, 6.08; N, 18.09. Found: C, 72.56; H, 5.99; N, 18.23.
2,4-Diamino-8,8-dimethyl-5-(3-nitrophenyl)-6-oxo-10-(phenylamino)-5,6,7,8,9,10-hexahydrobenzo[b][1,8]naphthyridine-3-carbonitrile (2j)
This compound was obtained in 87% yield (0.43 g) as a pale yellow solid; mp 231–232°C (dec); 1H NMR: δ 0.75 (s, 3H, CH3)*, 0.77 (s, 3H, CH3), 0.94 (s, 3H, CH3)*, 1.00 (s, 3H, CH3), 1.98 (d, 1H, J=16.6 Hz, CH2)*, 2.10 (d, 1H, J=16 Hz, CH2), 2.24 (d, 1H, J=16 Hz, CH2)*, 2.27 (d, 1H, J=16 Hz, CH2), 2.31 (d, 1H, J=18 Hz, CH2)*, 2.52 (d, 1H, J=18 Hz, CH2), 2.69 (d, 1H, J=18 Hz, CH2), 2.91 (d, 1H, J=18 Hz, CH2)*, 5.40 (s, 1H, CH)*, 5.48 (s, 1H, CH), 5.92 (s, 2H, NH2)*, 6.20 (s, 2H, NH2), 6.39 (s, 2H, NH2)*, 6.47 (s, 2H, NH2), 6.59 (d, 2H, J=8 Hz, C6H5)*, 6.74–6.80 (m, 1H, C6H5)*, 6.74–6.80 (m, 2H, C6H5), 6.84 (t, 1H, J=7 Hz, C6H5), 7.15–7.20 (m, 2H, C6H5), 7.15–7.20 (m, 2H, C6H5)*, 7.52 (t, 1H, J=8 Hz, C6H4)*, 7.56 (t, 1H, J=8 Hz, C6H4), 7.75 (dt, 1H, J=8 Hz, J=1 Hz, C6H4)*, 7.80 (dt, 1H, J=8 Hz, J=1 Hz, C6H4), 7.99 (ddd, 1H, J=8 Hz, J=2 Hz, J=1 Hz, C6H4)*, 8.04 (ddd, 1H, J=8 Hz, J=2 Hz, J=1 Hz, C6H4), 8.17 (t, 1H, J=2 Hz, C6H4), 8.26 (s, 1H, NH), 8.33 (t, 1H, J=2 Hz, C6H4)*, 8.66 (s, 1H, NH)*; IR: 3492, 3316 (NH2), 3238 (NH), 2198 (CN), 1660 cm−1 (C=O); MS: m/z (%) 495 [M]+ (17), 373 [M–122]+ (74), 93 [M–402]+ (100). Anal. Calcd for C27H25N7O3: C, 65.44; H, 5.09; N, 19.79. Found: C, 65.30; H, 5.00; N, 19.87.
Acknowledgment
This work was supported by a stipend of the President of the Russian Federation for young scientists and graduate students (SP-2141.2016.4).
References
[1] Zhu, S.; Zhang, Q.; Gudise, C.; Meng, L.; Wei, L.; Smith, E.; Kong, Y. Synthesis and evaluation of naphthyridine compounds as antimalarial agents. Bioorg. Med. Chem. Lett.2007, 17, 6101–6106.10.1016/j.bmcl.2007.09.044Search in Google Scholar PubMed PubMed Central
[2] Peraman, R; Varma, R. V.; Reddy, Y. P. Re-engineering nalidixic acid’s chemical scaffold: A step towards the development of novel anti-tubercular and anti-bacterial leads for resistant pathogens. Bioorg. Med. Chem. Lett.2015, 25, 4314–4319.10.1016/j.bmcl.2015.07.071Search in Google Scholar PubMed
[3] Huang, X. G.; Zhang, A. Q.; Chen, D. L.; Jia, Z. H.; Li, X. S. 4-Substituted 4-(1H-1,2,3-triazol-1-yl)piperidine: novel C7 moieties of fluoroquinolones as antibacterial agents. Bioorg. Med. Chem. Lett.2010, 20, 2859–2863.10.1016/j.bmcl.2010.03.044Search in Google Scholar PubMed
[4] Srivastava, S. K.; Jaggi, M.; Singh, A. T.; Madan, A.; Rani, N.; Vishnoi, M.; Agarwal, S. K.; Mukherjee, R.; Burman, A. C. Anticancer and anti-inflammatory activities of 1,8-naphthyridine-3-carboxamide derivatives. Bioorg. Med. Chem. Lett.2007, 17, 6660–6664.10.1016/j.bmcl.2007.08.006Search in Google Scholar PubMed
[5] Roma, G.; Di Braccio, M.; Grossi, G.; Piras, D.; Ballabeni, V.; Tognolini, M.; Bertoni, S.; Barocelli, E. 1,8-Naphthyridines VIII. Novel 5-aminoimidazo[1,2-a] [1,8]naphthyridine-6-carboxamide and 5-amino[1,2,4]triazolo[4,3-a] [1,8]naphthyridine-6-carboxamide derivatives showing potent analgesic or anti-inflammatory activity, respectively, and completely devoid of acute gastrolesivity. Eur. J. Med. Chem.2010, 45, 352–366.10.1016/j.ejmech.2009.10.020Search in Google Scholar PubMed
[6] Di Braccio, M.; Grossi, G.; Roma, G. D.; Piras, D.; Mattioli, F.; Gosmar, M. 1,8-Naphthyridines VI. Synthesis and anti-inflammatory activity of 5-(alkylamino)-N,N-diethyl[1,2,4]triazolo[4,3-a][1,8]naphthyridine-6-carboxamides with a new substitution pattern on the triazole ring. Eur. J. Med. Chem.2008, 43, 584–594.10.1016/j.ejmech.2007.04.016Search in Google Scholar PubMed
[7] Rudys, S.; Ríos-Luci, C.; Pérez-Roth, E.; Cikotiene, I.; Padrón, J. M. Antiproliferative activity of novel benzo[b][1,6]naphthyridines in human solid tumor cell lines. Bioorg. Med. Chem. Lett.2010, 20, 1504–1506.10.1016/j.bmcl.2010.01.112Search in Google Scholar PubMed
[8] Manera, C.; Saccomanni, G.; Malfitano, A. M.; Bertini, S.; Castelli, F.; Laezza, C.; Ligresti, A.; Lucchesi, V.; Tuccinardi, T.; Rizzolio, F.; Bifulco, M.; Di Marzo, V.; Giordano, A.; Macchia, M.; Martinelli, A. Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: An investigation of the 1,8-naphthyridin-2(1H)-one scaffold. Eur. J. Med. Chem.2012, 52, 284–294.10.1016/j.ejmech.2012.03.031Search in Google Scholar PubMed
[9] Madaan, A.; Kumar, V.; Verma, R.; Singh, A. T.; Jain, S. K.; Jaggi, M. Anti-inflammatory activity of a naphthyridine derivative (7-chloro-6-fluoro-N-(2-hydroxy-3-oxo-1-phenyl-3-(phenylamino)propyl)-4-oxo-1-(prop-2-yn-1-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxamide) possessing in vitro anticancer potential. Int. Immunopharmacol.2013, 15, 606–613.10.1016/j.intimp.2013.01.011Search in Google Scholar PubMed
[10] Manera, C.; Malfitano, A. M.; Parkkari, T.; Lucchesi, V.; Carpi, S.; Fogli, S.; Bertini, S.; Laezza, C.; Ligresti, A.; Saccomanni, G.; et al. New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno–modulatory activity. Eur. J. Med. Chem.2015, 97, 10–18.10.1016/j.ejmech.2015.04.034Search in Google Scholar PubMed
[11] Kumar, V.; Jaggi, M.; Singh, A. T.; Madaan, A.; Sanna, V.; Singh, P.; Sharma, P. K.; Irchhaiya, R.; Burman, A. C. 1,8-Naphthyridine-3-carboxamide derivatives with anticancer and anti-inflammatory activity. Eur. J. Med. Chem.2009, 44, 3356–3362.10.1016/j.ejmech.2009.03.015Search in Google Scholar PubMed
[12] Nam, T.-G.; Rector, C. L.; Kim, H.-Y.; Sonnen, A. F.-P.; Meyer, R.; Nau, W. M.; Atkinson, J.; Rintoul, J.; Pratt, D. A.; Porter, N. A. Tetrahydro-1,8-naphthyridinol analogues of α-tocopherol as antioxidants in lipid membranes and low-density lipoproteins. J. Am. Chem. Soc.2007, 129, 10211–10219.10.1021/ja072371mSearch in Google Scholar PubMed
[13] Kaveevivitchai, N.; Chitta, R.; Zong, R. F.; El Ojaimi, M.; Thummel, R. P. A molecular light-driven water oxidation catalyst. J. Am. Chem. Soc.2012, 134, 10721–10724.10.1021/ja300797gSearch in Google Scholar PubMed
[14] Daw, P.; Ghatak, T.; Doucet, H.; Bera, J. K. Cyclometalations on the Imidazo[1,2-a][1,8]naphthyridine framework. Organometallics2013, 32, 4306–4313.10.1021/om4004658Search in Google Scholar
[15] Daw, P.; Petakamsetty, R.; Sarbajna, A.; Laha, S.; Ramapanicker, R.; Bera, J. K. A highly efficient catalyst for selective oxidative scission of olefins to aldehydes: abnormal-NHC–Ru(II) complex in oxidation chemistry. J. Am. Chem. Soc.2014, 136, 13987–13990.10.1021/ja5075294Search in Google Scholar PubMed
[16] Tao, J.; Song, P.; Sato, Y.; Nishizawa, S.; Teramae, N.; Tonga, A.; Xiang, Y. A label-free and sensitive fluorescent method for the detection of uracil-DNA glycosylase activity. Chem. Commun.2015, 51, 929–932.10.1039/C4CC06170ESearch in Google Scholar
[17] Li, H. J.; Fu, W. F.; Li, L.; Gan, X.; Mu, W. H.; Chen, W. Q.; Duan, X. M.; Song, H. B. Intense one- and two-photon excited fluorescent bis(BF2) core complex containing a 1,8-naphthyridine derivative. Org. Lett.2010, 12, 2924–2927.10.1021/ol1003725Search in Google Scholar PubMed
[18] Ghosh, K.; Sen, T.; Fröhlich, R. A naphthyridine-based receptor for sensing citric acid. Tetrahedron Lett.2007, 48, 2935–2938.10.1016/j.tetlet.2007.02.047Search in Google Scholar
[19] Nammalwar, B.; Murie, M.; Fortenberry, C.; Bunce, R. A. Quinoline- and 1,8-naphthyridine-3-carboxylic acids using a self-catalyzed Friedländer approach. Tetrahedron Lett. 2014, 55, 3181–3183.10.1016/j.tetlet.2014.04.010Search in Google Scholar
[20] Li, B.; Nguyen, S.; Huang, J.; Wang, G.; Wei, H.; Pereshivko, O. P.; Peshkov, V. A. Synthesis of 1,8-naphthyridines from 2-aminonicotinaldehydes and terminal alkynes. Tetrahedron Lett. 2016, 57, 1958–1962.10.1016/j.tetlet.2016.03.070Search in Google Scholar
[21] Litvinov, V. P. Chemistry and biological activities of 1,8-naphthyridines. Russ. Chem. Rev.2004, 73, 637–670.10.1070/RC2004v073n07ABEH000856Search in Google Scholar
[22] Anderson, D. R.; Hegde, S.; Reinhard, E.; Gomez, L.; Vernier, W. F.; Lee, L.; Liu, S.; Sambandam, A.; Snider, P. A.; Masih, L. Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2). Bioorg. Med. Chem. Lett.2005, 15, 1587–1590.10.1016/j.bmcl.2005.01.067Search in Google Scholar PubMed
[23] Ibrahim, M. A.; El-Gohary, N. M. Studies on the chemical transformations of 6-methylchromone-3-carbonitrile under nucleophilic conditions. J. Heterocycl. Chem.2016, 53, 859–864.10.1002/jhet.2355Search in Google Scholar
[24] Naidu, P. S.; Kolita, S.; Majumder, S.; Bhuyan, P. J. Three-component domino heteroannulation and synthesis of some novel hexahydropyrimido[4,5-b]-1,8-naphthyridine derivatives. Synthesis2015, 47, 701–711.10.1055/s-0034-1379639Search in Google Scholar
[25] Sun, F.; Zhu, F.; Shao, X.; Li, Z. One-pot, three-component synthesis of 1,8-naphthyridine derivatives from heterocyclic ketene aminals, malononitrile dimer, and aryl aldehydes. Synlett2015, 26, 2306–2312.10.1002/chin.201607176Search in Google Scholar
[26] Shaabani, A.; Hooshmand, S. E.; Tabatabaei, A. T. Synthesis of fully substituted naphthyridines: A novel domino four-component reaction in a deep eutectic solvent system based on choline chloride/urea. Tetrahedron Lett. 2015, 57, 351–353.10.1016/j.tetlet.2015.12.017Search in Google Scholar
[27] Li, J.; Yu, Y.; Tu, M.-S.; Jiang, B.; Wang, Sh.-L.; Tu, Sh.-J. New domino heteroannulation of enaminones: synthesis of diverse fused naphthyridines. Org. Biomol. Chem. 2012, 10, 5361–5365.10.1039/c2ob25349fSearch in Google Scholar PubMed
[28] Bardasov, I. N.; Alekseeva, A. Yu.; Malyshkina, N. L.; Ershov, O. V.; Grishanov, D. A. One-step synthesis of chromeno[2,3-b]pyridines. Russ. J. Org. Chem. 2016, 52, 830–833.10.1134/S1070428016060117Search in Google Scholar
[29] Bardasov, I. N.; Alekseeva, A. U.; Mihailov; D. L.; Ershov, O. V.; Grishanov, D. A. Double heteroannulation reactions of 1-naphthol with alkyl- and arylmethylidene derivatives of malononitrile dimer. Tetrahedron Lett. 2015, 56, 1830–1832.10.1016/j.tetlet.2015.02.081Search in Google Scholar
[30] Alekseeva, A. Yu.; Mihailov, D. L.; Bardasov, I. N.; Timrukova, D. V.; Ershov O. V. Three-component synthesis of 5-aryl-1,8-naphthyridine-3-carbonitriles. Russ. J. Org. Chem.2016, 52, 1463–1467.10.1134/S1070428016100158Search in Google Scholar
[31] Alekseeva, A. Yu.; Mihailov, D. L., Bardasov, I. N.; Ershov, O. V.; Nasakin, O. E.; Lyshchikov, O. N. Heterocyclization of michael adducts of β-diketones with arylmethylidene derivatives of malononitrile dimers. Russ. J. Org. Chem. 2014, 50, 244–250.10.1134/S1070428014020171Search in Google Scholar
©2017 Walter de Gruyter GmbH, Berlin/Boston
This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Articles in the same Issue
- Frontmatter
- Review
- Chemical and pharmacological research on the plants from genus Ajuga
- Research Articles
- One-pot synthesis of annulated 1,8-naphthyridines
- Visible-light mediated regioselective (phenylsulfonyl)difluoromethylation of fused imidazoles with iododifluoromethyl phenyl sulfone
- Synthesis of thienopyrimidine-pyrazolo[3,4-b]pyridine hybrids
- Regioselective 1,4-conjugate aza-Michael addition of dienones with benzotriazole
- A simple one-pot synthesis of 2,4-diaryl- 9H-pyrido[2,3-b]indoles under solvent-free conditions
- Cyclodimerization of 3-phenacylideneoxindolines with amino esters for the synthesis of dispiro[indoline-3,1′-cyclopentane-3′,3″-indolines]
- An efficient approach to the synthesis of coumarin-fused dihydropyridinones
- Halogenoheterocyclization of terminally substituted 2-allylthio(seleno)quinolin- 3-carbaldehydes
- A new synthetic route to benzophenone derivatives
- Design, synthesis, docking and in vitro antifungal study of 1,2,4-triazole hybrids of 2-(aryloxy)quinolines
- Synthesis, antimicrobial activity and anti-biofilm activity of novel tetrazole derivatives
Articles in the same Issue
- Frontmatter
- Review
- Chemical and pharmacological research on the plants from genus Ajuga
- Research Articles
- One-pot synthesis of annulated 1,8-naphthyridines
- Visible-light mediated regioselective (phenylsulfonyl)difluoromethylation of fused imidazoles with iododifluoromethyl phenyl sulfone
- Synthesis of thienopyrimidine-pyrazolo[3,4-b]pyridine hybrids
- Regioselective 1,4-conjugate aza-Michael addition of dienones with benzotriazole
- A simple one-pot synthesis of 2,4-diaryl- 9H-pyrido[2,3-b]indoles under solvent-free conditions
- Cyclodimerization of 3-phenacylideneoxindolines with amino esters for the synthesis of dispiro[indoline-3,1′-cyclopentane-3′,3″-indolines]
- An efficient approach to the synthesis of coumarin-fused dihydropyridinones
- Halogenoheterocyclization of terminally substituted 2-allylthio(seleno)quinolin- 3-carbaldehydes
- A new synthetic route to benzophenone derivatives
- Design, synthesis, docking and in vitro antifungal study of 1,2,4-triazole hybrids of 2-(aryloxy)quinolines
- Synthesis, antimicrobial activity and anti-biofilm activity of novel tetrazole derivatives